Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
President & CEO, Director
-
Stock Symbol
-
CRNX on Nasdaq
Richard Scott Struthers - trading volume in the past year for Crinetics Pharmaceuticals, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
571K |
$28.2M |
$49.40 |
May 8, 2024 |
By Family Trust 1 |
|
|
| Common Stock |
257K |
$12.7M |
$49.40 |
May 8, 2024 |
Direct |
|
|
| Common Stock |
110K |
$5.43M |
$49.40 |
May 8, 2024 |
By Family Trust 2 |
|
|
| Common Stock |
110K |
$5.43M |
$49.40 |
May 8, 2024 |
By Family Trust 3 |
|
|
| Common Stock |
110K |
$5.43M |
$49.40 |
May 8, 2024 |
By Family Trust 4 |
|
|
| Common Stock |
1K |
$49.4K |
$49.40 |
May 8, 2024 |
By Spouse |
|
|
| Incentve stock option (Right to Buy) |
151K |
|
|
Aug 14, 2023 |
Direct |
Common Stock |
|
| Incentive stock option (Right to Buy) |
101K |
|
|
Nov 9, 2023 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
16.3K |
|
|
May 8, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.